Replies to post #253390 on Innovation Pharmaceuticals Inc (IPIX)

[MackG]

"A simple swish and spit should easily trump an intravenous alternative and the common sense logic of that is undeniable." And there in lies the value. I love seeing the Baystreet coverage of B-OM popping up elsewhere. Little IPIX and its massive potential with B and K won't languish much longer!

[bradfordbros]

When Galera found their investor they were sold on their OM drug. Good for them but if Ipix's B-OM is going to be better let's get the word out. And of course it helps Ipix your suggestion it might not is ridiculous.

[PlentyParanoid]

Some lightweight pondering.

LR, I did a real quickie calculation. If I am correct Galera has around 140 M$ in equity funding (I assume most of it VC) when series A, B and C are combined. Plus some multiple of $80M payable as future royalties. According to link below that would put Galera's future sale/IPO value (assuming successful P3) above 1.5 B$. Probably in the neighborhood of $3B.

http://www.angelblog.net/Venture_Capital_Funds_How_the_Math_Works.html

Caveat: Heavy involvement of big pharma venture funds (Novo Nordisk and Novartis) may bring estimate lower. As far as I know, big pharma funds tend to operate with lower return expectations (because they can afford to) than traditional venture capital.

As I said this is pondering with not much thought put into it. What the above means for IPIX is anybody's guess.